Efficacy of NICE Classification in the Histological Evaluation of Colorectal Lesions
Launched by SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE · Jan 9, 2014
Trial Information
Current as of July 03, 2025
Unknown status
Keywords
ClinConnect Summary
Many reports have demonstrated the efficacy of narrow band imaging (NBI) with magnification in predicting the histology and invasion depth of colorectal polyps. In China, however, the magnifying endoscope is not used in some medical centers. Even in centers equipped with this technique, the magnifying colonoscope is not sufficiently used in daily practice. Recently, a simple category classification (NICE classification) using non-magnified NBI has been proposed, which classifies colorectal tumors into types 1-3 based on different characteristics of color, surface pattern, and microvessels. ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with colorectal lesions during colonoscopy examination
- • Informed consent available
- Exclusion Criteria:
- • Suspect of advanced colorectal cancer
- • History of colorectal surgery, familial adenomatous polyposis or inflammatory bowel disease
- • Poor bowel preparation
- • Patients under unsuitable conditions for examination or treatment, such as acute upper gastrointestinal bleeding, noncorrectable coagulopathy, severe systemic disease, etc
About Shanghai Jiao Tong University School Of Medicine
Shanghai Jiao Tong University School of Medicine is a leading academic institution in China, renowned for its commitment to advancing medical research and education. As a prominent clinical trial sponsor, the school leverages its extensive expertise in biomedical sciences and innovative healthcare solutions to conduct rigorous clinical studies aimed at improving patient outcomes. With a focus on collaboration and translational research, the institution fosters partnerships with healthcare providers, industry leaders, and regulatory bodies to ensure the highest standards of scientific integrity and ethical conduct in clinical trials. Through its research initiatives, Shanghai Jiao Tong University School of Medicine strives to contribute significantly to the global medical community and enhance the quality of healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, , China
Patients applied
Trial Officials
Zhizheng Ge, MD,Ph.D
Principal Investigator
Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai ,China.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials